a public good project by the
Synthesis
Company
of California

© 2026

MARIE‐LOUISE BERGLUND | doi.page

0 works0 citations0 h-index

Google Scholar OpenAlex

MARIE‐LOUISE BERGLUND

AstraZeneca (Sweden)(SE)

Research Areas

Diabetes Treatment and Management, Ion Transport and Channel Regulation, Neuroendocrine Tumor Research Advances

Most-Cited Works

→ Chloride‐Transport Inhibitors in Vitro Do Not Inhibit Intestinal Fluid Secretion in Vivo(1989)6 cited